Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Amazing Meds vs NowPatient

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.5

Amazing Meds

Best for patients seeking compounded retatrutide access (with eyes open about regulatory status)

Starting at $199/mo

CompoundedSemaglutideTirzepatideRetatrutide
Visit Amazing Meds
7.1

NowPatient

Best for early adopters who want Foundayo via a one-stop telehealth platform

Starting at $199/mo

FoundayoTelehealthBrand Name
Visit NowPatient

Side-by-Side Comparison

FeatureAmazing MedsNowPatient
Overall Score7.5/107.1/10
Starting Price$199/mo$199/mo
Customer Rating
Features6 features3 features
States Available5051
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Amazing Meds

Pros

  • One of the very few US clinics offering compounded retatrutide
  • Board-certified D.O. medical director
  • Limited insurance acceptance (Cigna, BCBS)
  • Free consultations

Cons

  • Compounded retatrutide is regulatorily ambiguous (Phase 3 investigational drug)
  • Lower trust score because retatrutide is not FDA-approved and lacks the safety dataset of approved GLP-1s

NowPatient

Pros

  • Confirmed early Foundayo channel (April 2026 rollout)
  • Daily oral pill — no needles, no refrigeration
  • Telehealth consultation included

Cons

  • Pricing tier not yet publicly verified — confirm directly with the provider
  • State-by-state availability still being phased in
  • Lower mean weight loss vs injectable GLP-1s (~11.1% vs 14.9% Wegovy and 20.9% Zepbound at labeled max)

Our Verdict

Winner: Amazing MedsScore: 7.5/10

Amazing Meds edges out NowPatient with a higher overall score of 7.5/10 and is particularly strong for patients seeking compounded retatrutide access (with eyes open about regulatory status). NowPatient remains a solid alternative, especially if you're looking for early adopters who want Foundayo via a one-stop telehealth platform.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.